HFSA Board Certification Review 2021
Heart Failure Fundamentals (Pre-Recorded)
Heart Failure Epidemiology and Risk Factors
Sadiya Khan
Pathophysiology I: Cellular and Energetic Considerations
Daniel Burkhoff
Pathophysiology II: Hemodynamic, Structural, and Neurohormonal Considerations
Daniel Burkhoff
Diagnosis and Clinical Assessment
Mark Drazner
Cardio-Oncology for the HF boards
Bonnie Ky
Clinico-Pathologic Correlates in Heart Failure/ Images for the Heart Failure Boards
Jon Lomasney
Statistics for the HF Board
Brian Claggett
Cardiac Transplantation
Advanced Heart Failure: Defining the Phenotype and Patient Selection for Advanced Therapies
Nancy Sweitzer
Immunology: The Basics, PRA, Sensitization, Crossmatch
Sean Pinney
Rejection: Cellular and Antibody Mediated
Sean Pinney
Managing Immunosuppression and Drugs
Michelle Kittleson
Heart Transplant, Clinical Outcomes and Complications
Michelle Kittleson
Q&A Panel I
Akshay Desai, Nancy Sweitzer, Jonathan Rich, Maria Rosa
Key Issues in HF Management
Hemodynamics in HF I
James Fang
Hemodynamics in HF II
James Fang
Drug Therapy for Chronic HF I: Focus on established therapies (ACE/ARB/Beta-blocker/MRA/Digoxin/Hydralazine+Nitrates)
Clyde Yancy
Drug Therapy for Chronic HF II: Focus on newer therapies (Sacubitril/Valsartan, Ivabradine, SGLT2 inhibitors)
Mark Drazner
HFpEF: Epidemiology, Risk Factors, Diagnosis, Management (for the boards)
Sanjiv Shah
Pulmonary Hypertension
Jonathan Rich
Management of Common Arrhythmias I – Atrial Fib and Flutter
Roderick Tung
Management of Common Arrhythmias in HF II
Roderick Tung
Device Therapy in Heart Failure I – Sudden Death Prevention
Wendy Tzou
Device Therapy in Heart Failure II – CRT
Wendy Tzou
Management of the Hospitalized HF Patient
Maria Rosa Costanzo
Cardio Renal Failure Interactions in Heart Failure
Jeff Testani
Specific Heart Failure Syndromes
Specific Etiologies of HF I: Common Etiologies (CAD, ETOH, Peripartum, Myocarditis)
Akshay Desai
Specific Etiologies of HF II: Inherited HF syndromes (including HCM, ARVC, and LVNC)
Jane Wilcox
Specific Etiologies of HF III: Infiltrative Disorders and Restrictive Cardiomyopathy (Amyloidosis, Sarcoidosis, Hemochromatosis, Fabry)
Sanjiv Shah
Q&A Panel II
Akshay Desai, Nancy Sweitzer, Jonathan Rich, Maria Rosa
Guest: James Fang
Shock/MCS
Cardiogenic Shock Management
Nancy Sweitzer
MCS I: Durable MCS Devices and Outcomes
Joseph Rogers
MCS II: Temporary Support Devices and ECMO for the Boards
Jennifer Cowger
MCS III: MCS Complications and Patient Management
Jennifer Cowger
MCS IV: Interactive Shock and Device Management
Daniel Burkhoff, Jennifer Cowger, Joseph Rogers, Nancy Sweitzer
Special Topics in HF
Assessment of Functional Capacity including cardiopulmonary exercise testing
Gregory Lewis
Adult Congenital Heart Disease for the HF Specialist
Eric Krieger
Issues in Chronic HF Disease Management (Biomarkers, Remote Monitoring, Lifestyle Interventions)
Akshay Desai
Management of Valvular Heart Disease in Heart Failure (including functional MR, low gradient AS, tricuspid regurgitation)
Jane Wilcox
Management of Comorbidities in Heart Failure – Diabetes, Sleep Disorders, Iron Deficiency/Anemia, COPD
Maria Rosa Costanzo
Q&A Panel III
Akshay Desai, Nancy Sweitzer, Jonathan Rich
